DK104389A - Anvendelse af imidazolderivater - Google Patents

Anvendelse af imidazolderivater

Info

Publication number
DK104389A
DK104389A DK104389A DK104389A DK104389A DK 104389 A DK104389 A DK 104389A DK 104389 A DK104389 A DK 104389A DK 104389 A DK104389 A DK 104389A DK 104389 A DK104389 A DK 104389A
Authority
DK
Denmark
Prior art keywords
imidazold
derivatives
imidazold derivatives
Prior art date
Application number
DK104389A
Other languages
English (en)
Other versions
DK104389D0 (da
DK175428B1 (da
Inventor
Michael Brian Tyers
Teresa Elizabeth Challoner
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10632894&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK104389(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DK104389D0 publication Critical patent/DK104389D0/da
Publication of DK104389A publication Critical patent/DK104389A/da
Application granted granted Critical
Publication of DK175428B1 publication Critical patent/DK175428B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK198901043A 1988-03-04 1989-03-03 Anvendelse af imidazolderivater DK175428B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8805269 1988-03-04
GB888805269A GB8805269D0 (en) 1988-03-04 1988-03-04 Medicaments

Publications (3)

Publication Number Publication Date
DK104389D0 DK104389D0 (da) 1989-03-03
DK104389A true DK104389A (da) 1989-09-05
DK175428B1 DK175428B1 (da) 2004-10-18

Family

ID=10632894

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198901043A DK175428B1 (da) 1988-03-04 1989-03-03 Anvendelse af imidazolderivater

Country Status (23)

Country Link
US (2) US6544550B1 (da)
JP (1) JPH0296525A (da)
KR (1) KR890014109A (da)
AT (1) AT400301B (da)
AU (1) AU626010B2 (da)
BE (1) BE1002255A5 (da)
CA (1) CA1319323C (da)
CH (1) CH678149A5 (da)
CY (1) CY1634A (da)
CZ (1) CZ402391A3 (da)
DE (1) DE3906883C2 (da)
DK (1) DK175428B1 (da)
FR (1) FR2627986B1 (da)
GB (2) GB8805269D0 (da)
HK (1) HK41792A (da)
IE (1) IE61516B1 (da)
IT (1) IT1232662B (da)
NL (1) NL194463C (da)
NZ (1) NZ228214A (da)
SE (1) SE508342C2 (da)
SG (1) SG9092G (da)
SK (1) SK402391A3 (da)
ZA (1) ZA891639B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9101221D0 (en) * 1991-01-19 1991-02-27 Smithkline Beecham Plc Pharmaceuticals
US5929059A (en) * 1991-01-19 1999-07-27 Smithkline Beecham P.L.C. Pharmaceutical compositions containing granisetron and dexamethasone
EP1082959A1 (en) * 1991-09-20 2001-03-14 Glaxo Group Limited NK1 Antagonists for the treatment of depression
EP0688216A1 (en) * 1993-03-08 1995-12-27 Fujisawa Pharmaceutical Co., Ltd. Medicament for treating or preventing cerebrovascular diseases
US5661142A (en) * 1996-04-17 1997-08-26 Naeger; David M. Anti-emetic composition
US7288660B2 (en) * 2004-05-07 2007-10-30 Taro Pharmaceutical Industries Limited Process for preparing ondansetron hydrochloride dihydrate having a defined particle size
US20050277624A1 (en) * 2004-06-09 2005-12-15 Nigel Cook Use of corticosteroids alone or in conjunction with nutritional therapy to reduce stress in animals
US20060263421A1 (en) * 2005-05-18 2006-11-23 Abeille Pharmaceuticals Inc Transdermal Method and Patch for Nausea

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2561244B1 (fr) * 1984-01-25 1988-03-04 Glaxo Group Ltd Composes heterocycliques du type tetrahydrocarbazolone, procede pour leur preparation et composition pharmaceutique les comprenant
EP0191562B1 (en) * 1985-01-23 1991-07-10 Glaxo Group Limited Tetrahydrocarbazolone derivatives
EP0405617A3 (en) * 1985-03-14 1992-11-25 Beecham Group P.L.C. Medicaments for the treatment of anxiety
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
GB8628475D0 (en) * 1986-11-28 1987-01-07 Glaxo Group Ltd Medicaments
AU618520B2 (en) * 1986-12-17 1992-01-02 Glaxo Group Limited Medicaments
US4920219A (en) * 1988-11-29 1990-04-24 Rorer Pharmaceutical Corp. Substituted saturated and unsaturated indole quinoline and benzazepine carboxamides and their use as pharmacological agents
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy
US5246709A (en) * 1990-09-10 1993-09-21 Alza Corporation Antiemetic therapy

Also Published As

Publication number Publication date
IE890697L (en) 1989-09-04
SE8900751D0 (sv) 1989-03-03
SK402391A3 (en) 2000-12-11
NL194463B (nl) 2002-01-02
AU626010B2 (en) 1992-07-23
NZ228214A (en) 1997-02-24
AU3097689A (en) 1989-09-07
IT1232662B (it) 1992-03-02
CA1319323C (en) 1993-06-22
GB2216414B (en) 1991-12-11
US5482716A (en) 1996-01-09
GB8904881D0 (en) 1989-04-12
SG9092G (en) 1992-03-20
BE1002255A5 (fr) 1990-11-06
CH678149A5 (da) 1991-08-15
IE61516B1 (en) 1994-11-16
FR2627986A1 (fr) 1989-09-08
SE8900751L (sv) 1989-09-05
HK41792A (en) 1992-06-19
CY1634A (en) 1992-11-06
DK104389D0 (da) 1989-03-03
SE508342C2 (sv) 1998-09-28
ZA891639B (en) 1990-03-28
NL8900526A (nl) 1989-10-02
GB2216414A (en) 1989-10-11
KR890014109A (ko) 1989-10-21
DE3906883C2 (de) 1998-11-05
US6544550B1 (en) 2003-04-08
IT8947713A0 (it) 1989-03-03
CZ402391A3 (en) 1993-04-14
ATA48389A (de) 1995-04-15
FR2627986B1 (fr) 1994-03-04
AT400301B (de) 1995-12-27
DE3906883A1 (de) 1989-09-14
JPH0296525A (ja) 1990-04-09
DK175428B1 (da) 2004-10-18
NL194463C (nl) 2002-05-03
GB8805269D0 (en) 1988-04-07

Similar Documents

Publication Publication Date Title
DK528289A (da) Derivater af oploeseligt t-4
DE68925161D1 (de) Alkylavermectin-Derivate
DK363887D0 (da) Anvendelse af bromcruptin
DK608888A (da) Anvendelse af polysaccharidderivater
DK372089A (da) Anvendelse af isoquinolinderivater
DK273089D0 (da) Anvendelse af peptidderivater
DE68927657D1 (de) Butynylaminderivate
DK104389A (da) Anvendelse af imidazolderivater
DK120389D0 (da) Anvendelse af progestin
DK80990A (da) Sulfonylderivater af thien-triazol-diazepin
DK104489A (da) Anvendelse af triazolderivater
DK102389D0 (da) Anvendelse af interleukin
DE3824433A1 (de) Fluorcyclopropyl-derivate
DK316589D0 (da) Substituerede azacyclohexylderivater af rifamyciner
DK562289A (da) Anvendelse af somatostatiner
ATA155589A (de) Mitomycinphosphat-derivate
DK324489D0 (da) Substituerede azacyclohexylderivater
DK326789D0 (da) Fremstilling af homonojirimycin-derivater
DK289987D0 (da) Anvendelse af avaron- og avarolderivater
DK289887A (da) Anvendelse af avaron- og avarolderivater
DK0402857T3 (da) Anvendelse af 17beta-cyclopropylamino-androsten-derivater
IT8847653A0 (it) Sizzante comprendente 5 - idroscomposizione farmaceutica anoressitrpofano
DK118189A (da) Anvendelse af piperazinderivat
DK171688D0 (da) Anvendelse af indolderivater
DK333587A (da) Anvendelse af pyridinderivater

Legal Events

Date Code Title Description
PUP Patent expired